Inventor · disambiguated record
Paul F. Robbins
Also filed as: ROBBINS PAUL · ROBBINS PAUL F · ROBBINS PAUL FREDERIC
21 granted patents·15 pending applications·223 citations·filing 1995–2025
94Inventor score
Files withUS HEALTH26ROBBINS PAUL F2THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES2NAT INST HEALTH1THE UNITED STATES OF AMERICA A REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVI1
Top patents by PatentIndex Score
36 records- 0197US8088379B2Modified T cell receptors and related materials and methodsROBBINS PAUL F·Filed 2007·Granted Jan 3, 2012·127 cites·31 claims
- 0296US11208456B2Anti-KRAS-G12D T cell receptorsUS HEALTH·Filed 2020·Granted Dec 28, 2021·8 cites·36 claims
- 0394US10611816B2Anti-KRAS-G12D T cell receptorsUS HEALTH·Filed 2017·Granted Apr 7, 2020·9 cites·17 claims
- 0494US9128080B2Modified T cell receptors and related materials and methodsROBBINS PAUL F·Filed 2011·Granted Sep 8, 2015·18 cites·18 claims
- 0590US9879065B2T cell receptors recognizing MHC class II-restricted MAGE-A3US HEALTH·Filed 2013·Granted Jan 30, 2018·11 cites·35 claims
- 0688US12391742B2Anti-KRAS-G12D T cell receptorsUS HEALTH·Filed 2024·Granted Aug 19, 2025·0 cites·20 claims
- 0788US11897933B2Anti-KRAS-G12D T cell receptorsUS HEALTH·Filed 2021·Granted Feb 13, 2024·1 cites·35 claims
- 0888US2025340611A1Anti-kras-g12d t cell receptorsTHE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES·Filed 2025·Application pending·0 cites
- 0987US11306131B2T cell receptors recognizing HLA-A1- or HLA-CW7-restricted mageUS HEALTH·Filed 2018·Granted Apr 19, 2022·2 cites·26 claims
- 1083US12404317B2T cell receptors recognizing MHC class II-restricted MAGE-A3US HEALTH·Filed 2022·Granted Sep 2, 2025·0 cites·20 claims
- 1181US10611815B2T cell receptors recognizing MHC class II-restricted MAGE-A3US HEALTH·Filed 2017·Granted Apr 7, 2020·1 cites·30 claims
- 1281US2025059508A1Methods of isolating t cells having antigenic specificity for a cancer-specific mutationUS HEALTH·Filed 2024·Application pending·0 cites
- 1378US12441778B2T cell receptors recognizing HLA-A1-restricted MAGE-A3US HEALTH·Filed 2022·Granted Oct 14, 2025·0 cites·22 claims
- 1478US11840561B2Anti-KRAS-G12D T cell receptorsUS HEALTH·Filed 2021·Granted Dec 12, 2023·0 cites·26 claims
- 1577US2025250318A1Hla class ii-restricted t cell receptors against mutated rasTHE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES·Filed 2025·Application pending·0 cites
- 1676US12304940B2HLA class II-restricted t cell receptors against mutated RASUS HEALTH·Filed 2022·Granted May 20, 2025·0 cites·22 claims
- 1774US11939365B2T cell receptors recognizing mutated P53US HEALTH·Filed 2018·Granted Mar 26, 2024·1 cites·19 claims
- 1873US7501501B2MHC-Class II restricted melanoma antigens and their use in therapeutic methodsUS SEC DEP OF HEALTH AND HUMAN·Filed 2004·Granted Mar 10, 2009·4 cites·20 claims
- 1971US12171818B2Methods of isolating T cells having antigenic specificity for a cancer-specific mutationUS HEALTH·Filed 2021·Granted Dec 24, 2024·0 cites·20 claims
- 2071US10973894B2Methods of isolating T cells having antigenic specificity for a cancer-specific mutationUS HEALTH·Filed 2014·Granted Apr 13, 2021·0 cites·15 claims
- 2171US2024270814A1T cell receptors recognizing mutated p53THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2024·Application pending·0 cites
- 2270US5843648AP15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methodsUS HEALTH·Filed 1995·Granted Dec 1, 1998·33 cites·14 claims
- 2370US2023203124A1Methods of isolating t cell receptors having antigenic specificity for a cancer-specific mutationTHE UNITED STATES OF AMERICA A REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVI·Filed 2022·Application pending·0 cites
- 2469US2024263136A1Methods of preparing an isolated population of dendritic cells and methods of treating cancer using sameUS HEALTH·Filed 2024·Application pending·0 cites
- 2567US11306132B2HLA class II-restricted T cell receptors against mutated RASUS HEALTH·Filed 2018·Granted Apr 19, 2022·0 cites·30 claims
- 2667US2020270329A1T cell receptors recognizing mhc class ii-restricted mage-a3THE UNITED STATES OF AMERICAAS REPRESENTED BY THE SECRETARYDEPARTMENT OF HEALTH AND HUMAN SERVICES·Filed 2020·Application pending·0 cites
- 2760US2024190940A1Hla class i-restricted t cell receptors against ras with q61k mutationTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERICE·Filed 2022·Application pending·0 cites
- 2855US2009311279A1Colorectal Cancer AntigenNAT INST HEALTH·Filed 2004·Application pending·0 cites
- 2955US2014378389A1T cell receptors recognizing hla-a1- or hla-cw7-restricted mageUS HEALTH·Filed 2012·Application pending·0 cites
- 3053US11976299B2Methods of preparing an isolated population of dendritic cells and methods of treating cancer using sameUS HEALTH·Filed 2017·Granted May 7, 2024·0 cites·8 claims
- 3153US2017218042A1Methods of isolating t cell receptors having antigenic specificity for a cancer-specific mutationUS HEALTH·Filed 2014·Application pending·0 cites
- 3251US6951917B1MHC-class II restricted melanoma antigens and their use in therapeutic methodsUS HEALTH·Filed 1995·Granted Oct 4, 2005·8 cites·61 claims
- 3351US2023258635A1T cell phenotypes associated with response to adoptive cell therapyUS HEALTH·Filed 2021·Application pending·0 cites
- 3451US2010297093A1Modified t cell receptors and related materials and methodsUS HEALTH·Filed 2008·Application pending·0 cites
- 3550US2023183802A1Methods of isolating t cells and t-cell receptors from peripheral blood by single-cell analysis for immunotherapyUS HEALTH·Filed 2021·Application pending·0 cites
- 3648US2023138309A1Methods of isolating t-cells and t-cell receptors from tumor by single-cell analysis for immunotherapyUS HEALTH·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul F. Robbins files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →